- Previous Close
293.77 - Open
297.89 - Bid 260.00 x 800
- Ask 292.18 x 900
- Day's Range
291.27 - 299.40 - 52 Week Range
265.00 - 415.73 - Volume
657,985 - Avg. Volume
665,785 - Market Cap (intraday)
21.256B - Beta (5Y Monthly) 1.00
- PE Ratio (TTM)
41.74 - EPS (TTM)
7.02 - Earnings Date Oct 24, 2024 - Oct 28, 2024
- Forward Dividend & Yield 0.80 (0.27%)
- Ex-Dividend Date Jul 31, 2024
- 1y Target Est
353.18
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
www.westpharma.com10,600
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: WST
View MorePerformance Overview: WST
Trailing total returns as of 8/8/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WST
View MoreValuation Measures
Market Cap
21.31B
Enterprise Value
21.18B
Trailing P/E
41.79
Forward P/E
43.67
PEG Ratio (5yr expected)
5.70
Price/Sales (ttm)
7.61
Price/Book (mrq)
8.27
Enterprise Value/Revenue
7.36
Enterprise Value/EBITDA
27.69
Financial Highlights
Profitability and Income Statement
Profit Margin
18.25%
Return on Assets (ttm)
10.66%
Return on Equity (ttm)
19.72%
Revenue (ttm)
2.88B
Net Income Avi to Common (ttm)
524.9M
Diluted EPS (ttm)
7.02
Balance Sheet and Cash Flow
Total Cash (mrq)
446.2M
Total Debt/Equity (mrq)
12.19%
Levered Free Cash Flow (ttm)
172.09M
Research Analysis: WST
View MoreCompany Insights: WST
WST does not have Company Insights
Research Reports: WST
View MoreRaising target price to $320.00
WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $320.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $314.00
WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $314.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetWest Pharmaceutical Earnings: Disappointing Performance; Guidance Revised Down; Shares Undervalued
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
RatingPrice TargetWest Earnings: First-Quarter Revenue Slightly Better Than Expected; Maintaining Our Fair Value
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
RatingPrice Target